House Dust Mite Allergy Trial In Children

NCT ID: NCT04145219

Last Updated: 2024-06-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1460 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-12

Study Completion Date

2023-04-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A research study of how house dust mite tablets work compared to placebo in children aged between 5 and 11 years and who have allergy to house dust mites (MATIC)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial aims to demonstrate efficacy of the House Dust Mite SLIT-tablet compared to placebo in children (5-11 years of age) with House Dust Mite allergic rhinitis based on the total combined rhinitis symptoms and medication score during the last 8 weeks of treatment.

In addition, the trial will evaluate safety and tolerability of the treatment, and assess whether treatment has an impact on asthma symptoms and medication use, immunological parameters, and rhinoconjunctivitis quality of life (QoL).

The trial is a randomised, parallel-group, double-blind, placebo-controlled multi-national phase III trial conducted in Europe and North America. The treatment period will be approximately 1 year.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergic Rhinitis Due to Dermatophagoides Farinae Allergic Rhinitis Due to Dermatophagoides Pteronyssinus Allergic Rhinitis Due to House Dust Mite

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
Double-blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active treatment

HDM SLIT-tablet plus allergy and asthma rescue medication

Group Type EXPERIMENTAL

Sublingual allergy immunotherapy tablet

Intervention Type BIOLOGICAL

For daily administration (1 tablet per day)

Placebo

Placebo oral tablet plus allergy and asthma rescue medication

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

For daily administration (1 tablet per day)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sublingual allergy immunotherapy tablet

For daily administration (1 tablet per day)

Intervention Type BIOLOGICAL

Placebo

For daily administration (1 tablet per day)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Acarizax Odactra Placebo sublingual tablet

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female subjects aged 5-11 years
* A clinical history of HDM AR/C (Allergic rhinitis/rhinoconjunctivitis) (with or without asthma) and with allergic rhinitis symptoms despite having received allergy pharmacotherapy during the previous year prior to screening
* Have a certain level of AR (Allergic rhinitis) symptoms on at least 8 of the last 14 days of the baseline period
* Use symptomatic medication for treatment of HDM allergic rhinitis during at least 8 of the last 14 days of the baseline period
* Positive skin prick test (SPT) and IgE (Immunoglobulin E) to D. pteronyssinus or D. farinae at screening
* Lung function ≥ 70% of predicted value

Exclusion Criteria

* Sensitised and regularly exposed to perennial allergens
* Any nasal or pharyngeal condition that could interfere with the safety or efficacy evaluation
* Asthma requiring treatment with high dose of inhaled corticosteroid
* A relevant history of systemic allergic reaction
Minimum Eligible Age

5 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ALK-Abelló A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antje Schuster, MD

Role: PRINCIPAL_INVESTIGATOR

Professor of Pediatrics, Düsseldorf University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Allergy & Asthma Specialists Medical Group and Research Center

Huntington Beach, California, United States

Site Status

California Allergy and Asthma Medical Group

Los Angeles, California, United States

Site Status

Allergy & Asthma Medical Group and Research Center, A P.C.

San Diego, California, United States

Site Status

Miami Clinical Research

Miami, Florida, United States

Site Status

Pensacola Research Consultants, Inc. d.b.a. Avanza Medical Research Center

Pensacola, Florida, United States

Site Status

Sarasota Clinical Research

Sarasota, Florida, United States

Site Status

GCP, Global Clinical Professionals

St. Petersburg, Florida, United States

Site Status

Aeroallergy Research Labs of Savannah, Inc.

Savannah, Georgia, United States

Site Status

Clinical Research Atlanta

Stockbridge, Georgia, United States

Site Status

Deaconess Clinic Allergy

Evansville, Indiana, United States

Site Status

PMG Research of McFarland Clinic

Ames, Iowa, United States

Site Status

Clinical Research Institute

Minneapolis, Minnesota, United States

Site Status

University of Missouri

Columbia, Missouri, United States

Site Status

Clinical Research of The Ozarks Inc

Warrensburg, Missouri, United States

Site Status

Summit Medical Group

Berkeley Heights, New Jersey, United States

Site Status

Allergy & Asthma Associates of Monmouth City

Little Silver, New Jersey, United States

Site Status

Allergy Partners of Western North Carolina

Asheville, North Carolina, United States

Site Status

The Children's Research Institute, Department of Pediatrics, University of North Carolina Children's Hospital

Chapel Hill, North Carolina, United States

Site Status

UNC Children's Raleigh

Raleigh, North Carolina, United States

Site Status

Bernstein Clinical Research Center

Cincinnati, Ohio, United States

Site Status

Allergy, Asthma & Clinical Research Center

Oklahoma City, Oklahoma, United States

Site Status

Oklahoma Institute of Allergy & Asthma Clinical Research, LLC

Oklahoma City, Oklahoma, United States

Site Status

Vital Prospects Clinical Research Institute, P.C.

Tulsa, Oklahoma, United States

Site Status

The Corvallis Clinic

Corvallis, Oregon, United States

Site Status

West Ashley office: Charleston Allergy & Asthma

Charleston, South Carolina, United States

Site Status

ADAC Research, PA

Greenville, South Carolina, United States

Site Status

Charleston Allergy & Asthma

Summerville, South Carolina, United States

Site Status

Biogenics Research Institute

San Antonio, Texas, United States

Site Status

Allergy, Asthma & Sinus Center, S.C.

Greenfield, Wisconsin, United States

Site Status

Multiprofile Hospital for active treatment, Department of Pediatrics

Gabrovo, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment, Department of Pediatrics

Kyustendil, , Bulgaria

Site Status

University Multiprofile Hospital for Active Treatment Sveti Georgi EAD

Plovdiv, , Bulgaria

Site Status

University Multiprofile Hospital for Active Treatment "Sveti Georgi" EAD

Plovdiv, , Bulgaria

Site Status

Multiprofile Hospital for Active Treatment, Department of pneumology and phthisiatrics

Razgrad, , Bulgaria

Site Status

Outpatient Clinic for individual practice for specialized outpatient medical care in Allergology

Razgrad, , Bulgaria

Site Status

Specialized Hospital For Active Treatment of Pneumo - Phtisiatric Diseases Dr Dimitar Gramatikov - Ruse

Rousse, , Bulgaria

Site Status

Acibadem City Clinic Multiprofile Hospital for Active Treatment Tokuda, EAD, Clinic in Pediatrics

Sofia, , Bulgaria

Site Status

Sv. Vratch and Sv.Sv. Kuzma i Damian

Sofia, , Bulgaria

Site Status

Alitea-Med-Medical-Center

Sofia, , Bulgaria

Site Status

Diagnostic-Consultative center Ritam TR

Stara Zagora, , Bulgaria

Site Status

Halton Pediatric Allergy

Burlington, , Canada

Site Status

Triple A Lab

Hamilton, , Canada

Site Status

Kingston General Hospital - Division of Allergy & Immunology

Kingston, , Canada

Site Status

CHU Ste-Justine

Montreal, , Canada

Site Status

The Montreal Children's Hospital

Montreal, , Canada

Site Status

Niagara Clinical Research

Niagara Falls, , Canada

Site Status

Gordon Sussman Clinical Research, Inc.

North York, , Canada

Site Status

Clinique spécialisée en allergie de la capitale

Québec, , Canada

Site Status

Hospital for Sick Children

Toronto, , Canada

Site Status

Joel Liem Medicine Professional Corporation

Windsor, , Canada

Site Status

Hôpital Morvan - Service de Pédiatrie

Brest, , France

Site Status

CHU de Montpellier - Service Pneumologie et Addictologie

Montpellier, , France

Site Status

Kinderarztpraxis Bramsche

Bramsche, , Germany

Site Status

HNO praxis - Dr Yury Yarin

Dresden, , Germany

Site Status

Klinikum der Johann-Wolfgang-Goethe Universität - Zentrum f. Kinder- u. Jugendmedizin

Frankfurt, , Germany

Site Status

GMAP/HNO am Neckar

Heidelberg, , Germany

Site Status

CD8 klinika

Kaunas, , Lithuania

Site Status

Siauliai Republican Hospital

Šiauliai, , Lithuania

Site Status

JSC Seimos gydytojas

Vilnius, , Lithuania

Site Status

Center of Allergy Diagnosis and Treatment

Vilnius, , Lithuania

Site Status

Inlita JSC, Santara KTC

Vilnius, , Lithuania

Site Status

Indywidualna Specjalistyczna Praktyka Lekarska Elzbieta Matusz

Gryfice, , Poland

Site Status

Specjalistyczna Praktyka Lekarska Dr n. med. Joanna Orlicz-Widawska

Katowice, , Poland

Site Status

Centrum Medyczne ALL-MED

Krakow, , Poland

Site Status

Centrum Medyczne Plejady

Krakow, , Poland

Site Status

Poradnia Alergologiczna

Lodz, , Poland

Site Status

Poradnia Alergologiczna

Lodz, , Poland

Site Status

Alergotest s.c. Specjalistyczne Centrum Medyczne Andrzej Emeryk

Lublin, , Poland

Site Status

Centrum Alergologii Teresa Hofman Sp. z o.o.

Poznan, , Poland

Site Status

Podkarpacki Ośrodek Pulmonologii i Alergologii Sp. z o.o.

Rzeszów, , Poland

Site Status

Prywatny Gabinet Lekarski Malgorzata Pawlukiewicz

Rzeszów, , Poland

Site Status

IRMED Irena Wojciechowska

Warsaw, , Poland

Site Status

All-Med" Specjalistyczna Opieka Medyczna, Medyczny Instytut Badawczy Marek Jutel

Wroclaw, , Poland

Site Status

City Children's Hospital

Kolpino, , Russia

Site Status

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Krasnoyarsk, , Russia

Site Status

NRC Institute of Immunology

Moscow, , Russia

Site Status

Moscow City Children's Hospital No 9

Moscow, , Russia

Site Status

City Сhildren's Сlinical Polyclinic No5

Perm, , Russia

Site Status

I.P. Pavlov Ryazan State Medical University

Ryazan, , Russia

Site Status

Medical Technologies" Ltd.

Saint Petersburg, , Russia

Site Status

City Children's Polyclinic No44

Saint Petersburg, , Russia

Site Status

ArsVitae Severo-Zapad LLC

Saint Petersburg, , Russia

Site Status

North-Western State Medical University named after I.I. Mechnikov, Ministry of Public Health of Russian Federation

Saint Petersburg, , Russia

Site Status

Сurator LLC

Saint Petersburg, , Russia

Site Status

City Children's Polyclinic No45

Saint Petersburg, , Russia

Site Status

Сity Children's Polyclinic No 35

Saint Petersburg, , Russia

Site Status

Smolensk State Medical University

Smolensk, , Russia

Site Status

Scientific Medical Center for General Therapy and Pharmacology

Stavropol, , Russia

Site Status

Regional Children's Hospital

Tomsk, , Russia

Site Status

Alersa, s.r.o, Ambulancia klinickej alergológie a imunológie

Košice, , Slovakia

Site Status

Ambulancia klinickej imunologie a alergologie

Levice, , Slovakia

Site Status

ALFA EL, Imunoalergologická ambulancia

Poprad, , Slovakia

Site Status

Ambulancia klinickej imunologie a alergologie

Šurany, , Slovakia

Site Status

Hospital Vall d'Hebron

Barcelona, , Spain

Site Status

Hospital Sant Joan de Deu

Esplugues de Llobregat, , Spain

Site Status

Hospital Universitario de Jerez de la Frontera

Jerez de la Frontera, , Spain

Site Status

Hospital de Sagunto

Sagunto, , Spain

Site Status

Hospital de Sagunto

Valencia, , Spain

Site Status

Hospital la Plana

Villarreal, , Spain

Site Status

Chernivtsi Regional Children's Clinical Hospital, Department of Pediatrics and Children's Infectious Diseases

Chernivtsi, , Ukraine

Site Status

Clinical Emergency Hospital" of Dnipro City Council, Department of Pediatric Allergology at the Allergology Center

Dnipro, , Ukraine

Site Status

Dnipro City Children's Municipal Clinical Hospital #2

Dnipro, , Ukraine

Site Status

City Children's Clinic № 16" of Kharkiv City Council

Kharkiv, , Ukraine

Site Status

City Children's Clinical Hospital # 19" of Kharkiv City Council

Kharkiv, , Ukraine

Site Status

Kryvyi Rih City Clinical Hospital #8'' of Kryvyi Rih City Council, Department of Pediatric Pulmonology; State Institution "Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine

Kryvyi Rih, , Ukraine

Site Status

O.S. Kolomiychenko Institute, Center of Allergic Diseases of Upper Respiratory Ways and Ear

Kyiv, , Ukraine

Site Status

State Institution Phthisiology and Pulmonology Institute named after F.G. Yanovskyy of NAMS of Ukraine

Kyiv, , Ukraine

Site Status

Institute of Pediatrics, Obstetrics and Gynecology named after Academician O. M. Lukianova of the National Academy of Medical Sciences of Ukraine

Kyiv, , Ukraine

Site Status

Communal Nonprofit Enterprise "Lviv City Children's Clinical Hospital", Allergology Department, Lviv City Children's Allergology Center

Lviv, , Ukraine

Site Status

Children's Clinical Hospital of Poltava Regional Council

Poltava, , Ukraine

Site Status

Regional Children Clinical Hospital, Infectious-Diagnostic Department

Sumy, , Ukraine

Site Status

Regional Children's Clinical Hospital of Vinnytsia Regional Council

Vinnytsia, , Ukraine

Site Status

City Children's Hospital #5" of Zaporizhzhya City Council, Allergology Department

Zaporizhzhya, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Bulgaria Canada France Germany Lithuania Poland Russia Slovakia Spain Ukraine

References

Explore related publications, articles, or registry entries linked to this study.

Schuster A, Caimmi D, Nolte H, Novakova S, Mikler J, Foss-Skiftesvik MH, Osterdal AS, Emeryk A, Gagnon R, Pfaar O. Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial. Lancet Reg Health Eur. 2024 Nov 26;48:101136. doi: 10.1016/j.lanepe.2024.101136. eCollection 2025 Jan.

Reference Type DERIVED
PMID: 39678704 (View on PubMed)

Field K, Blaiss MS. Sublingual Versus Subcutaneous Immunotherapy for Allergic Rhinitis: What Are the Important Therapeutic and Real-World Considerations? Curr Allergy Asthma Rep. 2020 Jun 16;20(9):45. doi: 10.1007/s11882-020-00934-4.

Reference Type DERIVED
PMID: 32548677 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MT-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

House Dust Mite SLIT in Elderly Patients
NCT01605760 COMPLETED PHASE4